These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15245691)

  • 1. When to treat patients with chronic hepatitis C.
    Heathcote J; Ramji A
    Curr Gastroenterol Rep; 2004 Aug; 6(4):261-3. PubMed ID: 15245691
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic viral hepatitis.
    Henrion J
    Acta Clin Belg; 1999 Oct; 54(5):281-8. PubMed ID: 10555386
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C in patients with renal disease.
    Gane E
    Med J Malaysia; 2005 Jul; 60 Suppl B():72-6. PubMed ID: 16108179
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions.
    Douglas SD
    Brain Behav Immun; 2005 Jan; 19(1):20-2. PubMed ID: 15581734
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Matthews AM; Fireman M; Zucker B; Sobel M; Hauser P
    Am J Psychiatry; 2006 Aug; 163(8):1342-7; quiz 1479. PubMed ID: 16877644
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevalence and clinical course in HBV and HCV dual chronic infection].
    Tamori A; Nishiguchi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):667-70. PubMed ID: 15359882
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of conventional interferon and ribavirin combination therapy in chronic Hepatitis C patients in Pakistan.
    Bukhsh A; Goh BH; Lee LH; Khan TM
    J Infect Public Health; 2017; 10(5):692-693. PubMed ID: 28209323
    [No Abstract]   [Full Text] [Related]  

  • 8. First-line treatments for hepatitis C.
    Messori A; Del Santo F; Maratea D
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1383-5. PubMed ID: 21569068
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
    Chung RT; Gale M; Polyak SJ; Lemon SM; Liang TJ; Hoofnagle JH
    Hepatology; 2008 Jan; 47(1):306-20. PubMed ID: 18161743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 11. Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.
    Honda T; Toyoda H; Hayashi K; Katano Y; Yano M; Nakano I; Yoshioka K; Goto H; Yamamoto K; Takamatsu J
    JAMA; 2005 Mar; 293(10):1190-2. PubMed ID: 15755940
    [No Abstract]   [Full Text] [Related]  

  • 12. Up to date treatment of hepatitis C in adults.
    Schalm SW; Brouwer JT
    Acta Gastroenterol Belg; 1998; 61(4):397-9. PubMed ID: 9923088
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin for chronic hepatitis C.
    Ogana G; Tocco A; Garrucciu G; Branca B; Azara V; Manzoni NE; Deplano A; Solinas A
    J Clin Gastroenterol; 2001 Sep; 33(3):254-5. PubMed ID: 11500622
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    Alavian SM; Tabatabaei SV
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
    [No Abstract]   [Full Text] [Related]  

  • 15. Should routine screening for coeliac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C?
    Casella G; Bardella MT; Perego D; Baldini V
    Eur J Gastroenterol Hepatol; 2004 Apr; 16(4):429. PubMed ID: 15028979
    [No Abstract]   [Full Text] [Related]  

  • 16. Q & A with Karen Tashima, MD new direct-acting antiviral agents offer therapeutic revolution for hepatitis C virus infection.
    Korr M
    R I Med J (2013); 2014 Jul; 97(7):29-30. PubMed ID: 24983018
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders.
    Glaser D
    Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hepatitis C infection. A revolution should not hide another].
    Sogni P
    Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hepatitis C: therapeutic management].
    Bourliere M
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 2):S166-71. PubMed ID: 18482813
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C: current and future therapies.
    Mishra P; Jensen DM
    Mt Sinai J Med; 2008 Aug; 75(4):405-14. PubMed ID: 18729159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.